J Adv Pract Oncol. 2019 Aug;10(6):565-575. doi: 10.6004/jadpro.2019.10.6.6. Epub 2019 Aug 1.
of Wellmont Cancer Institute discusses results from a study in hormone receptor-positive metastatic breast cancer (MONALEESA-7), two studies in the metastatic HER2-positive setting (SOPHIA and NALA), as well as a new analysis of the TAILORx trial and a study on the effects of a low-fat diet on incidence and outcomes from the ASCO Annual Meeting, reported by .
韦尔蒙特癌症研究所讨论了一项关于激素受体阳性转移性乳腺癌的研究(MONALEESA - 7)的结果、两项转移性HER2阳性情况下的研究(SOPHIA和NALA),以及TAILORx试验的一项新分析和一项关于低脂饮食对美国临床肿瘤学会年会报告的发病率和预后影响的研究。